FM
EGRX

Fondren Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Fondren Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15,000
Closed -$604K – 105
2018
Q4 		$604K Buy
+15,000
New +$604K 0.79% 37
2017
Q4 		– Sell
-15,100
Closed -$901K – 59
2017
Q3 		$901K Buy
+15,100
New +$901K 0.72% 24